Search for: "Abbott Laboratories, Inc."
Results 381 - 400
of 450
Sort by Relevance
|
Sort by Date
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) Products… [read post]
31 Oct 2008, 3:32 am
Opposing Federal Circuit Preliminary Injunction Standards in Abbott Laboratories v. [read post]
29 Oct 2008, 4:53 am
Opposing Federal Circuit Preliminary Injunction Standards in Abbott Laboratories v. [read post]
25 Oct 2008, 12:03 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Biaxin (Clarithromycin) - US: New standard for materiality: Abbott Laboratories v. [read post]
23 Oct 2008, 10:31 am
" Specifically, "infections triggered safety alerts for the arthritis medicines Enbrel (etanercept), sold by Amgen Inc.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]
21 Oct 2008, 8:37 pm
Earlier today, October 21, 2008, the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
21 Oct 2008, 8:37 pm
Earlier today, October 21, 2008, the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
2 Oct 2008, 12:36 pm
Abbott Laboratories, 447 F.3d 861, 867 (5th Cir. 2006), the court blew out this type of claim, finding the defendant's warning about high blood pressure sufficient and that there was no need to go further ant tell doctors about what high blood pressure itself can cause. [read post]
19 Sep 2008, 6:00 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Sep 2008, 11:15 am
Texas Attorney General Greg Abbott announced a $28 million civil settlement with Abbott Laboratories Inc.The settlement resolves the state's claims that the drug manufacturer falsely reported drug prices to the state and federal Medicaid programs. [read post]
9 Sep 2008, 12:06 am
"Swanson's (aka Abbott's) Case: Abbott Laboratories ("Abbott") licensed Swanson's patent, and sued Syntron Bioresearch, Inc. for infringement. [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
8 Aug 2008, 2:44 am
Lawsuits filed in Oakland federal court claim that Abbott Laboratories Inc. raised the price of its AIDS drug Norvir by 400 percent in an attempt to increase sales of its drug Kaletra and suppress competition. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
28 Jul 2008, 7:01 pm
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
22 Jul 2008, 3:10 pm
Valproate is sold as Depakote by Abbott Laboratories and as Depakine by Sanofi-Aventis. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
14 Jul 2008, 3:55 am
Abbott Laboratories v. [read post]
8 Jul 2008, 1:00 pm
Some of the tops selling epilepsy medication that can be affected by the warning are GlaxoSmithKline Plc's Lamictal, Pfizer Inc's Lyrica, Johnson & Johnson's Topamax and Abbott Laboratories Inc's Depakote. [read post]
